Homann Dirk, Eisenbarth George S
Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado, USA.
J Clin Invest. 2006 May;116(5):1212-5. doi: 10.1172/JCI28506.
Autoimmune diseases such as the diabetes that develops in NOD mice depend on immunologic recognition of specific autoantigens, but recognition can result in a pathogenic or protective T cell response. A study by Du et al. in this issue of the JCI demonstrates that TGF-beta signaling by T cells recognizing the insulin peptide B:9-23 is essential for such protection and that this inhibitory cytokine functions in both a paracrine and an autocrine manner (see the related article beginning on page 1360). We propose that the insulin peptide B:9-23 and a conserved TCR motif form an "immunologic homunculus" underlying the relatively common targeting of insulin by T cells that, as demonstrated by the study of Du and coworkers, results in a protective T cell response, or diabetes, as shown by other investigators, for related T cell receptors.
自身免疫性疾病,如非肥胖糖尿病(NOD)小鼠所患的糖尿病,依赖于对特定自身抗原的免疫识别,但这种识别可能导致致病性或保护性的T细胞反应。Du等人在本期《临床研究杂志》(JCI)上发表的一项研究表明,识别胰岛素肽B:9-23的T细胞的转化生长因子-β(TGF-β)信号传导对于这种保护作用至关重要,并且这种抑制性细胞因子以旁分泌和自分泌方式发挥作用(见第1360页开始的相关文章)。我们提出,胰岛素肽B:9-23和一个保守的T细胞受体(TCR)基序形成了一个“免疫小矮人”,它是T细胞相对常见地靶向胰岛素的基础,正如Du及其同事的研究所证明的,这会导致保护性T细胞反应,而其他研究者的研究表明,对于相关的T细胞受体,会导致糖尿病。